The tumor microenvironment can induce the expression of inhibitory receptors and downregulate activating receptors involved in tumor cell recognition and killing, leading to impaired antitumor activity of NK cells.9,10 TGF-β converts effector NK cells into type 1 innate lymphocytes, leading to tumor immune evasion.11 This evidence concerns the gene TGFB1 and neoplasm.